Over the Counter (OTC) Analgesics Market Synopsis

Over the Counter (OTC) Analgesics Market Size Was Valued at USD 29.34 Billion in 2023, and is Projected to Reach USD 41.4 Billion by 2032, Growing at a CAGR of 3.9% From 2024-2032.

Over-the-counter (OTC) analgesics are medications that are available without a prescription and are used to relieve pain and reduce fever. They are commonly used to alleviate minor aches and pains such as headaches, muscle aches, backaches, menstrual cramps, and toothaches. OTC analgesics work by blocking the production of chemicals in the body that cause pain and inflammation.

• Over-the-counter (OTC) analgesics are non-prescription medications used to relieve pain and reduce fever. They are commonly used for various medical conditions and symptoms. Common applications include headaches, muscle pain, arthritis, menstrual cramps, toothaches, back pain, fever, minor injuries, post-surgery pain, and general pain relief. Headaches are relieved by acetaminophen, ibuprofen, and aspirin. Muscle pain is reduced by NSAIDs like ibuprofen and naproxen. Arthritis is alleviated by NSAIDs like ibuprofen and naproxen. Menstrual cramps are relieved by women using OTC analgesics.
• Temporary relief from toothaches and dental pain is provided by OTC analgesics. Back pain is managed by managing acute and chronic conditions. Minor injuries are alleviated by OTC analgesics. OTC analgesics are a popular choice for quick pain relief without a prescription, making them accessible to a broader population. They are typically more affordable than prescription medications, making them suitable for those without health insurance or seeking cost-effective treatment options. Many people prefer self-treatment for minor aches and pains, empowering them to manage their health independently.
• OTC analgesics come in various forms, such as tablets, capsules, liquids, creams, and patches, catering to different preferences and needs. They are known for their effectiveness in providing relief from various types of pain and improving the quality of life. They offer a non-invasive treatment option, making them a preferred first-line approach before more invasive treatments. Increased consumer awareness and education about OTC analgesics have contributed to their growing demand, ensuring safe and effective use.

Over the Counter (OTC) Analgesics Market Trend Analysis

Consumers are Familiar with OTC Analgesics Effective Pain Relief

• The demand for Over-the-Counter (OTC) analgesics is driven by the belief that consumers are familiar with these medications and trust them for safe and effective pain relief. This trust is based on the widespread use of OTC analgesics like acetaminophen, ibuprofen, and aspirin, which have become household staples for managing common ailments like headaches, muscle aches, and minor pains.
• The ease of access to these medications, which are readily available without a prescription at various stores, further reinforces this trust. Pharmaceutical companies invest in marketing campaigns to promote their products, emphasizing their safety, efficacy, and reliability. Positive experiences with OTC analgesics often lead to word-of-mouth recommendations, fostering trust and loyalty among friends, family, and peers.
• Healthcare professionals often recommend OTC analgesics for mild to moderate pain and fever treatment, reinforcing consumer trust. The safety profile and regulatory oversight of OTC analgesics ensure their safety, quality, and efficacy, enhancing consumer confidence in these medications. Overall, trust in OTC analgesics is a key driver in the market.

Restraint

Long-term or Excessive Use of OTC Analgesics can Cause Side Effects

• Over-the-counter (OTC) analgesics, such as NSAIDs, can pose significant health risks, including gastrointestinal issues, stomach bleeding, and liver damage. Regular use can mask underlying conditions, such as chronic headaches or joint pain, which require proper diagnosis and treatment.
• Long-term or excessive use of certain analgesics, particularly those containing caffeine or combination medications, can lead to medication overuse headaches, which can be a rebound effect when the pain-relieving effects wear off. Some individuals may develop tolerance to the effects of OTC analgesics, requiring higher doses to achieve the same level of pain relief.
• Dependence or addiction can also occur with certain medications, particularly opioids. Long-term use of OTC analgesics can increase the risk of drug interactions with other medications, potentially leading to adverse health outcomes. Continuous use of OTC analgesics can result in significant costs, especially for those without adequate insurance coverage or access to affordable healthcare.

Opportunity

Expansion into Emerging Markets

• The growth of Over-the-Counter (OTC) analgesics in emerging markets is driven by rising demand for affordable and accessible treatments for common ailments. The changing healthcare landscape in these markets is characterized by a greater emphasis on self-care and over-the-counter treatments, allowing consumers to tap into new consumer segments and expand their market reach.
• Retail expansion in emerging markets, such as pharmacies, convenience stores, and supermarkets, provides convenient access points for consumers to purchase OTC analgesics without a prescription. Manufacturers can tailor their products to meet the specific needs and preferences of consumers in these markets by developing culturally acceptable formulations, packaging sizes, and pricing strategies.
• Innovative dosage forms and educational initiatives can also help build trust and credibility in the market. The regulatory environment in many emerging markets allows for the sale of certain medications without a prescription, making it a favorable environment for OTC analgesics.

Challenge

Lack of Awareness or Understanding of Proper Usage, Dosage

• The lack of awareness and understanding about the proper usage and dosage of over-the-counter (OTC) analgesics is a significant issue in healthcare. It can lead to health risks such as liver damage and gastrointestinal bleeding. Misuse can occur due to a lack of awareness, leading to incorrect dosages or inappropriate use. Consumer confusion about the wide array of available OTC analgesics can also increase the risk of adverse effects.
• Insufficient education from healthcare providers or pharmacists can further exacerbate this issue. Language and literacy barriers can exacerbate the lack of understanding, leading to unintentional misuse or underutilization. Cultural beliefs and practices can also influence perceptions and behaviours, leading to misconceptions and traditional remedies, further contributing to the lack of awareness and understanding.

Over the Counter (OTC) Analgesics Market Segment Analysis:

Over the Counter (OTC) Analgesics Market is Segmented on the basis of type, form, and distribution channel.

By Type, Acetaminophen segment is expected to dominate the market during the forecast period

• Acetaminophen is a widely available over-the-counter (OTC) analgesics medication due to its wide availability, safety profile, versatility, paediatric use, consumer preference, and physician recommendation. It is widely available in pharmacies, grocery stores, and convenience stores, making it a convenient choice for consumers seeking pain relief.
• Acetaminophen is generally considered safe, with fewer gastrointestinal side effects compared to NSAIDs. It is effective for relieving mild to moderate pain and reducing fever, making it a versatile choice for various types of pain. It is also commonly recommended for children due to its safety profile. Healthcare professionals often recommend acetaminophen as a first-line treatment for pain relief.

By Form, Tablet segment held the largest share of 56.4% in 2023

• The tablet segment of over-the-counter (OTC) analgesics is the largest due to its convenience, precise dosing, longer shelf life, widespread consumer recognition, and manufacturing efficiency. Tablets are easy to store, transport, and consume, making them readily available and familiar to consumers.
• They also offer longer shelf life, reducing the risk of spoilage or degradation. Popular OTC analgesic brands are primarily available in tablet form, demonstrating widespread trust. However, consumer preferences and market dynamics may evolve, potentially impacting the dominance of specific forms.

Over the Counter (OTC) Analgesics Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast Period

• North America, with its high healthcare expenditures, is a prime market for OTC analgesics due to their widespread availability and accessibility. The region's robust pharmaceutical industry, with major players manufacturing and distributing OTC analgesics, drives innovation and product availability. Consumer preference for self-medication and the aging population, particularly in the US and Canada, fuels the demand for OTC analgesics.
• Pharmaceutical companies in North America invest heavily in marketing and advertising campaigns to raise awareness and drive sales. The regulatory environment in North America ensures product safety and efficacy, with consumers trusting OTC analgesics approved by authorities like the FDA and Health Canada.

Over the Counter (OTC) Analgesics Market Top Key Players:

• Johnson & Johnson (US)
• Pfizer Inc. (US)
• Prestige Consumer Healthcare Inc. (US)
• Procter & Gamble Co. (US)
• Prestige Brands Holdings, Inc. (US)
• Medterra (US)
• Mylan N.V. (US)
• Bayer AG (Germany)
• Boehringer Ingelheim GmbH (Germany)
• Merck KGaA (Germany)
• GlaxoSmithKline plc (UK)
• Reckitt Benckiser Group plc (UK)
• GlaxoSmithKline Consumer Healthcare Ltd. (UK)
• Sanofi S.A. (France)
• Endo International plc (Ireland)
• Novartis AG (Switzerland)
• Perrigo Company plc (Ireland)
• Aurobindo Pharma Limited (India)
• Sun Pharmaceutical Industries Ltd. (India)
• Cipla Limited (India)
• Taisho Pharmaceutical Holdings Co., Ltd. (Japan)
• Daiichi Sankyo Company, Limited (Japan)
• Takeda Pharmaceutical Company Limited (Japan)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Aspen Pharmacare Holdings Limited (South Africa), and other major players

Key Industry Developments in the Over the Counter (OTC) Analgesics Market:

• In December 2023, Pfizer Inc. announced the successful completion of its acquisition of Seagen Inc., a global biotechnology company specializing in discovering, developing, and commercializing transformative cancer medicines. Pfizer finalized its acquisition of all outstanding common stock of Seagen for $229 in cash per share, amounting to a total enterprise value of approximately $43 billion.
• In April 2024, Bayer and Evotec, the German-based life science company, announced an update to the focus of their strategic collaboration on April 30, 2024. They have shifted their attention to developing innovative precision treatments for cardiovascular diseases (CVDs). The collaboration's objective was to identify and validate novel targets, aiming to build a portfolio of precision cardiology therapeutics by utilizing Evotec's disease modeling capabilities with human induced pluripotent stem cells (iPSCs). iPSCs offered unique opportunities to uncover new disease mechanisms and pathways for novel treatments.

1. INTRODUCTION
   1. RESEARCH OBJECTIVES
   2. RESEARCH METHODOLOGY
   3. RESEARCH PROCESS
   4. SCOPE AND COVERAGE
      1. Market Definition
      2. Key Questions Answered
   5. MARKET SEGMENTATION
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
4. GROWTH OPPORTUNITIES BY SEGMENT
5. MARKET LANDSCAPE
   1. PORTER’S FIVE FORCES ANALYSIS
      1. Bargaining Power Of Supplier
      2. Threat Of New Entrants
      3. Threat Of Substitutes
      4. Competitive Rivalry
      5. Bargaining Power Among Buyers
   2. INDUSTRY VALUE CHAIN ANALYSIS
   3. MARKET DYNAMICS
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
   4. MARKET TREND ANALYSIS
   5. REGULATORY LANDSCAPE
   6. PESTLE ANALYSIS
   7. PRICE TREND ANALYSIS
   8. PATENT ANALYSIS
   9. TECHNOLOGY EVALUATION
   10. MARKET IMPACT OF THE RUSSIA-UKRAINE WAR
       1. Geopolitical Market Disruptions
       2. Supply Chain Disruptions
       3. Instability in Emerging Markets
   11. ECOSYSTEM
6. OVER THE COUNTER (OTC) ANALGESICS MARKET BY TYPE (2017-2030)
   1. OVER THE COUNTER (OTC) ANALGESICS MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. ACETAMINOPHEN
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2030F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2030F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS)
   5. ASPIRIN
7. OVER THE COUNTER (OTC) ANALGESICS MARKET BY FORM (2017-2030)
   1. OVER THE COUNTER (OTC) ANALGESICS MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. LIQUID
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2030F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2030F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. TABLET
   5. CAPSULE
8. OVER THE COUNTER (OTC) ANALGESICS MARKET BY DISTRIBUTION CHANNEL (2017-2030)
   1. OVER THE COUNTER (OTC) ANALGESICS MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. PHARMACIES/DRUG STORES
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2030F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2030F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. HOSPITAL PHARMACIES
   5. ONLINE RETAILERS
9. COMPANY PROFILES AND COMPETITIVE ANALYSIS
   1. COMPETITIVE LANDSCAPE
      1. Competitive Positioning
      2. Over the Counter (OTC) Analgesics Market Share By Manufacturer (2022)
      3. Industry BCG Matrix
      4. Heat Map Analysis
      5. Mergers & Acquisitions
      6. JOHNSON & JOHNSON (US)
      7. Company Overview
      8. Key Executives
      9. Company Snapshot
      10. Role of the Company in the Market
      11. Sustainability and Social Responsibility
      12. Operating Business Segments
      13. Product Portfolio
      14. Business Performance (Production Volume, Sales Volume, Sales Margin, Production Capacity, Capacity Utilization Rate)
      15. Key Strategic Moves And Recent Developments
      16. SWOT Analysis
   2. PFIZER INC. (US)
   3. PRESTIGE CONSUMER HEALTHCARE INC. (US)
   4. PROCTER & GAMBLE CO. (US)
   5. PRESTIGE BRANDS HOLDINGS, INC. (US)
   6. MEDTERRA (US)
   7. MYLAN N.V. (US)
   8. BAYER AG (GERMANY)
   9. BOEHRINGER INGELHEIM GMBH (GERMANY)
   10. MERCK KGAA (GERMANY)
   11. GLAXOSMITHKLINE PLC (UK)
   12. RECKITT BENCKISER GROUP PLC (UK)
   13. GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD. (UK)
   14. SANOFI S.A. (FRANCE)
   15. ENDO INTERNATIONAL PLC (IRELAND)
   16. NOVARTIS AG (SWITZERLAND)
   17. PERRIGO COMPANY PLC (IRELAND)
   18. AUROBINDO PHARMA LIMITED (INDIA)
   19. SUN PHARMACEUTICAL INDUSTRIES LTD. (INDIA)
   20. CIPLA LIMITED (INDIA)
   21. TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. (JAPAN)
   22. DAIICHI SANKYO COMPANY, LIMITED (JAPAN)
   23. TAKEDA PHARMACEUTICAL COMPANY LIMITED (JAPAN)
   24. TEVA PHARMACEUTICAL INDUSTRIES LTD. (ISRAEL)
   25. ASPEN PHARMACARE HOLDINGS LIMITED (SOUTH AFRICA)
10. GLOBAL OVER THE COUNTER (OTC) ANALGESICS MARKET BY REGION
    1. OVERVIEW
    2. NORTH AMERICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Type
       4. Historic And Forecasted Market Size By Form
       5. Historic And Forecasted Market Size By Distribution Channel
       6. Historic And Forecasted Market Size By Country
          1. USA
          2. Canada
          3. Mexico
    3. EASTERN EUROPE
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Russia
          2. Bulgaria
          3. The Czech Republic
          4. Hungary
          5. Poland
          6. Romania
          7. Rest Of Eastern Europe
    4. WESTERN EUROPE
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Germany
          2. United Kingdom
          3. France
          4. The Netherlands
          5. Italy
          6. Spain
          7. Rest Of Western Europe
    5. ASIA PACIFIC
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. China
          2. India
          3. Japan
          4. South Korea
          5. Malaysia
          6. Thailand
          7. Vietnam
          8. The Philippines
          9. Australia
          10. New-Zealand
          11. Rest Of APAC
    6. MIDDLE EAST & AFRICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Turkey
          2. Bahrain
          3. Kuwait
          4. Saudi Arabia
          5. Qatar
          6. UAE
          7. Israel
          8. South Africa
    7. SOUTH AMERICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Brazil
          2. Argentina
          3. Rest of South America
11. INVESTMENT ANALYSIS
12. ANALYST VIEWPOINT AND CONCLUSION
    1. Recommendations and Concluding Analysis
    2. Potential Market Strategies

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. OVER THE COUNTER (OTC) ANALGESICS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. OVER THE COUNTER (OTC) ANALGESICS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. OVER THE COUNTER (OTC) ANALGESICS MARKET COMPETITIVE RIVALRY
TABLE 005. OVER THE COUNTER (OTC) ANALGESICS MARKET THREAT OF NEW ENTRANTS
TABLE 006. OVER THE COUNTER (OTC) ANALGESICS MARKET THREAT OF SUBSTITUTES
TABLE 007. OVER THE COUNTER (OTC) ANALGESICS MARKET BY TYPE OF DRUG
TABLE 008. ACETAMINOPHEN MARKET OVERVIEW (2016-2030)
TABLE 009. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET OVERVIEW (2016-2030)
TABLE 010. SALICYLATES MARKET OVERVIEW (2016-2030)
TABLE 011. OTHER ANALGESICS MARKET OVERVIEW (2016-2030)
TABLE 012. OVER THE COUNTER (OTC) ANALGESICS MARKET BY FORM
TABLE 013. TABLET MARKET OVERVIEW (2016-2030)
TABLE 014. CAPSULE MARKET OVERVIEW (2016-2030)
TABLE 015. LIQUID MARKET OVERVIEW (2016-2030)
TABLE 016. OVER THE COUNTER (OTC) ANALGESICS MARKET BY DISTRIBUTION CHANNEL
TABLE 017. HOSPITAL PHARMACIES MARKET OVERVIEW (2016-2030)
TABLE 018. RETAIL PHARMACIES MARKET OVERVIEW (2016-2030)
TABLE 019. ONLINE PHARMACIES MARKET OVERVIEW (2016-2030)
TABLE 020. OTHER MARKET OVERVIEW (2016-2030)
TABLE 021. NORTH AMERICA OVER THE COUNTER (OTC) ANALGESICS MARKET, BY TYPE OF DRUG (2016-2030)
TABLE 022. NORTH AMERICA OVER THE COUNTER (OTC) ANALGESICS MARKET, BY FORM (2016-2030)
TABLE 023. NORTH AMERICA OVER THE COUNTER (OTC) ANALGESICS MARKET, BY DISTRIBUTION CHANNEL (2016-2030)
TABLE 024. N OVER THE COUNTER (OTC) ANALGESICS MARKET, BY COUNTRY (2016-2030)
TABLE 025. EASTERN EUROPE OVER THE COUNTER (OTC) ANALGESICS MARKET, BY TYPE OF DRUG (2016-2030)
TABLE 026. EASTERN EUROPE OVER THE COUNTER (OTC) ANALGESICS MARKET, BY FORM (2016-2030)
TABLE 027. EASTERN EUROPE OVER THE COUNTER (OTC) ANALGESICS MARKET, BY DISTRIBUTION CHANNEL (2016-2030)
TABLE 028. OVER THE COUNTER (OTC) ANALGESICS MARKET, BY COUNTRY (2016-2030)
TABLE 029. WESTERN EUROPE OVER THE COUNTER (OTC) ANALGESICS MARKET, BY TYPE OF DRUG (2016-2030)
TABLE 030. WESTERN EUROPE OVER THE COUNTER (OTC) ANALGESICS MARKET, BY FORM (2016-2030)
TABLE 031. WESTERN EUROPE OVER THE COUNTER (OTC) ANALGESICS MARKET, BY DISTRIBUTION CHANNEL (2016-2030)
TABLE 032. OVER THE COUNTER (OTC) ANALGESICS MARKET, BY COUNTRY (2016-2030)
TABLE 033. ASIA PACIFIC OVER THE COUNTER (OTC) ANALGESICS MARKET, BY TYPE OF DRUG (2016-2030)
TABLE 034. ASIA PACIFIC OVER THE COUNTER (OTC) ANALGESICS MARKET, BY FORM (2016-2030)
TABLE 035. ASIA PACIFIC OVER THE COUNTER (OTC) ANALGESICS MARKET, BY DISTRIBUTION CHANNEL (2016-2030)
TABLE 036. OVER THE COUNTER (OTC) ANALGESICS MARKET, BY COUNTRY (2016-2030)
TABLE 037. MIDDLE EAST & AFRICA OVER THE COUNTER (OTC) ANALGESICS MARKET, BY TYPE OF DRUG (2016-2030)
TABLE 038. MIDDLE EAST & AFRICA OVER THE COUNTER (OTC) ANALGESICS MARKET, BY FORM (2016-2030)
TABLE 039. MIDDLE EAST & AFRICA OVER THE COUNTER (OTC) ANALGESICS MARKET, BY DISTRIBUTION CHANNEL (2016-2030)
TABLE 040. OVER THE COUNTER (OTC) ANALGESICS MARKET, BY COUNTRY (2016-2030)
TABLE 041. SOUTH AMERICA OVER THE COUNTER (OTC) ANALGESICS MARKET, BY TYPE OF DRUG (2016-2030)
TABLE 042. SOUTH AMERICA OVER THE COUNTER (OTC) ANALGESICS MARKET, BY FORM (2016-2030)
TABLE 043. SOUTH AMERICA OVER THE COUNTER (OTC) ANALGESICS MARKET, BY DISTRIBUTION CHANNEL (2016-2030)
TABLE 044. OVER THE COUNTER (OTC) ANALGESICS MARKET, BY COUNTRY (2016-2030)
TABLE 045. JOHNSON & JOHNSON: SNAPSHOT
TABLE 046. JOHNSON & JOHNSON: BUSINESS PERFORMANCE
TABLE 047. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 048. JOHNSON & JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. BAYER AG: SNAPSHOT
TABLE 049. BAYER AG: BUSINESS PERFORMANCE
TABLE 050. BAYER AG: PRODUCT PORTFOLIO
TABLE 051. BAYER AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: SNAPSHOT
TABLE 052. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: BUSINESS PERFORMANCE
TABLE 053. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT PORTFOLIO
TABLE 054. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. PFIZER INC.: SNAPSHOT
TABLE 055. PFIZER INC.: BUSINESS PERFORMANCE
TABLE 056. PFIZER INC.: PRODUCT PORTFOLIO
TABLE 057. PFIZER INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. RECKITT BENCKISER GROUP PLC: SNAPSHOT
TABLE 058. RECKITT BENCKISER GROUP PLC: BUSINESS PERFORMANCE
TABLE 059. RECKITT BENCKISER GROUP PLC: PRODUCT PORTFOLIO
TABLE 060. RECKITT BENCKISER GROUP PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. SANOFI SA: SNAPSHOT
TABLE 061. SANOFI SA: BUSINESS PERFORMANCE
TABLE 062. SANOFI SA: PRODUCT PORTFOLIO
TABLE 063. SANOFI SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. SUN PHARMACEUTICAL INDUSTRIES LTD: SNAPSHOT
TABLE 064. SUN PHARMACEUTICAL INDUSTRIES LTD: BUSINESS PERFORMANCE
TABLE 065. SUN PHARMACEUTICAL INDUSTRIES LTD: PRODUCT PORTFOLIO
TABLE 066. SUN PHARMACEUTICAL INDUSTRIES LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 066. DR. REDDY'S LABORATORIES LTD: SNAPSHOT
TABLE 067. DR. REDDY'S LABORATORIES LTD: BUSINESS PERFORMANCE
TABLE 068. DR. REDDY'S LABORATORIES LTD: PRODUCT PORTFOLIO
TABLE 069. DR. REDDY'S LABORATORIES LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 069. NOVARTIS AG: SNAPSHOT
TABLE 070. NOVARTIS AG: BUSINESS PERFORMANCE
TABLE 071. NOVARTIS AG: PRODUCT PORTFOLIO
TABLE 072. NOVARTIS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 072. TEVA PHARMACEUTICAL INDUSTRIES LTD: SNAPSHOT
TABLE 073. TEVA PHARMACEUTICAL INDUSTRIES LTD: BUSINESS PERFORMANCE
TABLE 074. TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCT PORTFOLIO
TABLE 075. TEVA PHARMACEUTICAL INDUSTRIES LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 075. GLENMARK PHARMACEUTICALS LTD.: SNAPSHOT
TABLE 076. GLENMARK PHARMACEUTICALS LTD.: BUSINESS PERFORMANCE
TABLE 077. GLENMARK PHARMACEUTICALS LTD.: PRODUCT PORTFOLIO
TABLE 078. GLENMARK PHARMACEUTICALS LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 078. ALKEM LABORATORIES LIMITED: SNAPSHOT
TABLE 079. ALKEM LABORATORIES LIMITED: BUSINESS PERFORMANCE
TABLE 080. ALKEM LABORATORIES LIMITED: PRODUCT PORTFOLIO
TABLE 081. ALKEM LABORATORIES LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 081. LUPIN LIMITED: SNAPSHOT
TABLE 082. LUPIN LIMITED: BUSINESS PERFORMANCE
TABLE 083. LUPIN LIMITED: PRODUCT PORTFOLIO
TABLE 084. LUPIN LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 084. SANDOZ INTERNATIONAL GMBH: SNAPSHOT
TABLE 085. SANDOZ INTERNATIONAL GMBH: BUSINESS PERFORMANCE
TABLE 086. SANDOZ INTERNATIONAL GMBH: PRODUCT PORTFOLIO
TABLE 087. SANDOZ INTERNATIONAL GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 087. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 088. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 089. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 090. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. OVER THE COUNTER (OTC) ANALGESICS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. OVER THE COUNTER (OTC) ANALGESICS MARKET OVERVIEW BY TYPE OF DRUG
FIGURE 012. ACETAMINOPHEN MARKET OVERVIEW (2016-2030)
FIGURE 013. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET OVERVIEW (2016-2030)
FIGURE 014. SALICYLATES MARKET OVERVIEW (2016-2030)
FIGURE 015. OTHER ANALGESICS MARKET OVERVIEW (2016-2030)
FIGURE 016. OVER THE COUNTER (OTC) ANALGESICS MARKET OVERVIEW BY FORM
FIGURE 017. TABLET MARKET OVERVIEW (2016-2030)
FIGURE 018. CAPSULE MARKET OVERVIEW (2016-2030)
FIGURE 019. LIQUID MARKET OVERVIEW (2016-2030)
FIGURE 020. OVER THE COUNTER (OTC) ANALGESICS MARKET OVERVIEW BY DISTRIBUTION CHANNEL
FIGURE 021. HOSPITAL PHARMACIES MARKET OVERVIEW (2016-2030)
FIGURE 022. RETAIL PHARMACIES MARKET OVERVIEW (2016-2030)
FIGURE 023. ONLINE PHARMACIES MARKET OVERVIEW (2016-2030)
FIGURE 024. OTHER MARKET OVERVIEW (2016-2030)
FIGURE 025. NORTH AMERICA OVER THE COUNTER (OTC) ANALGESICS MARKET OVERVIEW BY COUNTRY (2016-2030)
FIGURE 026. EASTERN EUROPE OVER THE COUNTER (OTC) ANALGESICS MARKET OVERVIEW BY COUNTRY (2016-2030)
FIGURE 027. WESTERN EUROPE OVER THE COUNTER (OTC) ANALGESICS MARKET OVERVIEW BY COUNTRY (2016-2030)
FIGURE 028. ASIA PACIFIC OVER THE COUNTER (OTC) ANALGESICS MARKET OVERVIEW BY COUNTRY (2016-2030)
FIGURE 029. MIDDLE EAST & AFRICA OVER THE COUNTER (OTC) ANALGESICS MARKET OVERVIEW BY COUNTRY (2016-2030)
FIGURE 030. SOUTH AMERICA OVER THE COUNTER (OTC) ANALGESICS MARKET OVERVIEW BY COUNTRY (2016-2030)